Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

Press releases published on October 27, 2026

an hour ago

Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Indeterminate GlobeNewswire

an hour ago

NEXGEL Regains Compliance with Nasdaq Listing Requirement

Indeterminate GlobeNewswire

an hour ago

Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System

Indeterminate GlobeNewswire

an hour ago

Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

Indeterminate GlobeNewswire

an hour ago

Clearmind Successfully Completes Patient Recruitment for the First Alcohol Use Disorder Cohort of its CMND-100 Phase I/IIa Clinical Trial

Indeterminate GlobeNewswire

an hour ago

Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker

Indeterminate GlobeNewswire

2 hours ago

60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients

Indeterminate GlobeNewswire

2 hours ago

BillionToOne to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

Candel Therapeutics to Present at November Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

Human Appeal’s Winter Comedy Tour returns for the 12th year running in aid of orphaned children

Indeterminate GlobeNewswire

2 hours ago

Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026

Indeterminate GlobeNewswire

2 hours ago

Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline

Indeterminate GlobeNewswire

2 hours ago

Stryker to participate in the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

2 hours ago

vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems

Indeterminate GlobeNewswire

2 hours ago

Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results

Indeterminate GlobeNewswire

2 hours ago

Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH

Indeterminate GlobeNewswire

2 hours ago

AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year

Indeterminate GlobeNewswire

2 hours ago

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026

Indeterminate GlobeNewswire

2 hours ago

Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors

Indeterminate GlobeNewswire

2 hours ago

CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union

Indeterminate GlobeNewswire